Method of molding silicone elastomer drug carrier in an endocardial lead

• US 7,363,091 B1
• Filed: 12/09/2003
• Issued: 04/22/2008
• Est. Priority Date: 07/11/2001
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Chen, Cole H., Chitre, Yougandh, Doan, Phong D., Helland, John R.
• Primary Examiner(s): Schaetzle; Kennedy J.
• Assistant Examiner(s): Reidel; Jessica L.
• Application Number:
  US10/732,332
• Time in Patent Office: 1,596 Days
• Field of Search: 607/120, 607126-128, 607130-131, 264/267, 29857-858
• US Class Current: 607/120
• CPC Class Codes: A61N 1/0568 with drug delivery

Abstract

A drug-eluting endocardial lead and method of manufacture. The silicone elastomer of the present invention is ideally suited to a manufacturing environment due to its extended pot life and decreased curing time. A preferred silicone elastomer is comprised of a multi-part mixture having at least a base portion and a curing portion. Additionally, since curing does not begin until the base and curing portions are combined, the mixing can be physically undertaken closer to the location of the endocardial lead and the curing “clock” does not start until the mixing occurs and external heat is applied. Since the silicone elastomer formed by base and curing components have improved the pot life and curing characteristics, the mixture is suitable for mixing with a steroid and then dispensing into an endocardial lead tip thus eliminating current design limitations imposed by current art while concomitantly minimizing manufacturing costs.

Claims

1. A method to manufacture a drug-eluting lead comprising:

positioning a removable mold around a screw-in helix of the drug-eluding lead;

dispensing a liquid monolithic controlled release device (MCRD) mixture directly into the removable mold and onto a distal portion of the drug-eluting lead;

curing the liquid MCRD mixture into a drug-eluting plug; and

removing the removable mold after the MCRD mixture has cured;

wherein positioning the removable mold around the screw-in helix comprises positioning a distal end of the removable mold within a chamber of the drug-eluding lead, and wherein the chamber houses the screw-in helix when in a retracted position.

2. The method of claim 1, further comprising:

forming the liquid monolithic controlled release device (MCRD) mixture;

wherein the forming the liquid MCRD mixture comprises combining an inflammation-reducing drug with a drug carrying silicone elastomer.

3. The method of claim 2, wherein the inflammation-reducing drug is a steroid, and wherein the drug carrying silicone elastomer comprises a platinum catalyst as a curing component and dimethylsiloxane and a reinforcing silica as a base component.

4. The method of claim 1, further comprising:

dispensing the liquid MCRD mixture onto the screw-in helix;

wherein the drug-eluting plug is integral with the screw-in helix.

5. A method to manufacture a drug-eluting lead comprising:

positioning a screw-in helix within a chamber of the drug-eluding lead, a proximal portion of the screw-in helix coupled to a shaft;

positioning a removable mold within an inner coil diameter of the screw-in helix of the drug-eluding lead, wherein a distal portion of the removable mold is positioned at the shaft;

dispensing a liquid monolithic controlled release device (MCRD) mixture directly into the removable mold and onto a distal portion of the drug-eluting lead;

curing the liquid MCRD mixture into a drug-eluting plug; and

removing the removable mold after the MCRD mixture has cured;

wherein the drug-eluting plug is integral with the shaft; and

wherein the drug-eluting plug is disposed within an inner coil diameter of the screw-in helix.